Work

Response to Crizotinib in a Patient with MET-mutant Papillary Renal Cell Cancer After Progression on Tivantinib

Year: 2014

Type: article

Study design: Observational Study

Source: European Urology

DOI: 10.1016/j.eururo.2014.10.012

Authors: Mark N. Stein, Kim M. Hirshfield, Hua Zhong, Eric A. Singer, Siraj M. Ali, Shridar Ganesan

Institutions: Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Foundation Medicine (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2054797483

FWCI: 1.695

Cites: 9

Cited by: 12

Related to: 10